Autoantibodies, the immune system's antibodies directed against the body's own tissues, have emerged as crucial players in the pathogenesis of various autoimmune diseases. Over the years, extensive research has shed light on the significance of autoantibodies in disease diagnosis, prognosis and therapeutic interventions. This article explores the latest developments in autoantibody research and its potential translation into clinical applications. We discuss the significance of autoantibody biomarkers in disease diagnosis and monitoring, the potential of autoantibodybased therapies and the challenges and opportunities in integrating this knowledge into personalized medicine. The identification of specific autoantibody signatures holds the promise of revolutionizing clinical practice by enabling early detection, tailored treatment approaches and improved patient outcomes in various autoimmune conditions.
HTML PDFShare this article
Journal of Immunobiology received 34 citations as per Google Scholar report
